Prevalence and factors with potentially inappropriate prescribing among older outpatients with depression: a multicentre study across China
Fangyuan Tian, Zhaoyan Chen, Ying Zhang

TL;DR
This study found that over half of older outpatients with depression in China receive potentially inappropriate prescriptions, with factors like hospital level and polypharmacy contributing to the issue.
Contribution
The study provides new insights into the prevalence and risk factors of potentially inappropriate prescribing for depression in older adults in China.
Findings
The prevalence of potentially inappropriate prescriptions reached 50.42% among older outpatients with depression.
Polypharmacy and treatment in psychiatry departments were strongly associated with higher rates of inappropriate prescriptions.
Abstract
Older outpatients with depression are at high risk for potentially inappropriate prescription (PIP). This investigation sought to determine the frequency and associated factors of PIP within Chinese older adults. This cross-sectional study used prescription data from older outpatients with depression from 90 hospitals in seven cities in China from January–December 2021. Risk factor identification for PIP employed multivariate logistic regression analysis. Trend assessment was performed through joinpoint regression to calculate the average annual percent change. The prevalence of PIP reached 50.42%. The top five PIM were alprazolam, clonazepam, olanzapine, lorazepam, estazolam. The prevalence of PIP decreased from 51.56 to 50.99% (average annual percent change = −0.335%). Logistic regression demonstrated that tertiary-level hospital (odds ratio (OR) = 1.215; 95% confidence interval…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMental Health Treatment and Access · Pharmaceutical Practices and Patient Outcomes · Health Systems, Economic Evaluations, Quality of Life
